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An Aspirin a Day
In addition to sun avoidance, 
chemopreventive strategies are 
being explored as a means of 
reducing the risk of malignant 
melanoma. In a case–control 
study of 400 cases and 600 age- 
and gender-matched controls, 
Curiel-Lewandrowski and 
colleagues found that long-
term use of nonsteroidal anti-
inflammatory drugs for more 
than five years decreases the 
risk of cutaneous melanoma 
by half. In particular, aspirin 
use was associated with 
decreased risk of melanoma 
development. In combination 
with the known cardiovascular 
benefits of aspirin, these 
results support the evaluation 
of low-dose aspirin as a 
chemopreventive agent 
for melanoma in high-risk 
populations. See page 1460
It’s All Individual
Understanding DNA damage 
caused by UVA radiation 
is critical to developing 
strategies to minimize its 
skin cancer risk. Mouret and 
colleagues recently uncovered 
a correlation between 
the formation of the most 
frequent UVA-induced DNA 
photolesions—cyclobutane 
pyrimidine dimers (CPDs)—
and skin phototype and 
UVB minimum erythemal 
dose (MED). These results 
indicate that both MED and 
skin pigmentation predict 
the sensitivity of underlying 
DNA to induction of CPD in 
the skin after UVB and UVA 
irradiation. These data will aid 
in the delineation of individual 
sensitivities toward the adverse 
effects of solar UV radiation. 
See page 1539
Mutational Inquisition
Investigations of patients with autosomal dominant 
inheritance patterns of the aggressive chronic inflam-
matory skin disease hidradenitis suppurativa (or acne 
inversa) by two independent groups revealed novel 
mutations in PSENEN and NCSTN, genes that encode 
two of the four components integral to the γ-secretase 
endoprotease complex, which catalyzes cleavage of 
membrane proteins such as amyloid precursor protein 
and Notch receptors. Pink and colleagues identified mutations in these two genes 
in two of seven pedigrees examined, and Liu and colleagues found two NCSTN 
mutations in two affected families using exome sequencing techniques. Together, 
these results support a role for γ-secretase in the pathogenesis of this disease. 
See pages 1568 and 1570
Phototherapy Targets
To identify pathways involved in the anti-
inflammatory effects of narrow-band 
(NB) UVB phototherapy as a psoriasis 
treatment, Rácz and colleagues used 
gene expression profiling of lesional and 
nonlesional skin from eleven patients. 
Clinically effective NB-UVB therapy was 
determined to be associated with the sup-
pression of type I and type II interferon 
signaling, suppression of the T helper 
type 17 (Th17) pathway, and modulation 
of genes involved in epidermal differen-
tiation. The inhibition of the Th17 path-
way by NB-UVB was validated in an imiquimod-induced psoriasis-like dermatitis 
mouse model. Overall, the results implicate these pathways as targets of NB-UVB 
in the resolution of psoriatic inflammation. See page 1547
Antioxidant Shield
The cornified cell envelope (CE) is 
responsible for the physical and perme-
ability properties afforded by the bar-
rier function of the skin, an organ that is 
exposed to the highest levels of reactive 
oxygen species (ROS) that are generated 
from the atmosphere and UV irradiation. 
Vermeij and colleagues demonstrated that 
the CE serves as a first line of defense by 
quenching ROS directly. In addition, the 
small proline-rich CE precursor proteins 
play a major role in this ROS quench-
ing via the presence of redox-regulated cysteine residues. This function of the CE 
appears to protect cells by eliminating the majority of ROS at the cell periphery. 
See page 1435
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